Suppr超能文献

新型冠状病毒肺炎大流行期间中国炎症性肠病患者的自我报告治疗目标。

Self-reported Treatment Goals in Chinese Patients with Inflammatory Bowel Disease During the Coronavirus Disease 2019 Pandemic.

机构信息

Department of Gastroenterology, China Medical University First Affiliated Hospital, Shenyang City, Liaoning Province, China.

出版信息

Turk J Gastroenterol. 2022 Jul;33(7):554-564. doi: 10.5152/tjg.2022.21180.

Abstract

BACKGROUND

Inflammatory bowel disease is a chronic recurrent disease, and the treatment goals of inflammatory bowel disease are mainly based on doctors' perspective, but there are some differences between the doctor's perspective and the patient's perspective. The aim of this study is to understand the treatment goals and the related factors from the patients' perspective during the coronavirus disease 2019 pandemic.

METHODS

A total of 212 participants were recruited to fill out the questionnaires including clinical characteristics and treatment goals. Eleven treatment goals were measured by a Short-Form 34 questionnaire. Univariate and multivariate regression analyses were used to explore the related factors about these treatment goals.

RESULTS

A total of 212 inflammatory bowel disease patients were enrolled in this study. The most concerned treatment goal was the improvement of quality of life (mean score was 8.54), while mean score of ulcerative colitis patients and Crohn's disease patients was 9.10 and 8.45, respectively. We had also found some related factors such as the type of disease, the course of disease, the frequency of hematochezia, and defecation.

CONCLUSION

Our survey showed that inflammatory bowel disease patients pay more attention to the improvement of quality of life and few drugs during the coronavirus disease 2019 pandemic. There are some related factors such as the type of disease, the course of dis- ease, the frequency of hematochezia, and defecation. Our results help clinicians understand the patients' treatment goals, which can contribute to better management of inflammatory bowel disease patients.

摘要

背景

炎症性肠病是一种慢性复发性疾病,炎症性肠病的治疗目标主要基于医生的视角,但医生视角与患者视角存在一些差异。本研究旨在了解在 2019 冠状病毒病大流行期间,从患者角度来看待治疗目标及其相关因素。

方法

共招募了 212 名参与者填写问卷,包括临床特征和治疗目标。使用短表 34 问卷测量了 11 个治疗目标。采用单变量和多变量回归分析探讨了这些治疗目标的相关因素。

结果

本研究共纳入了 212 例炎症性肠病患者。最关注的治疗目标是生活质量的改善(平均得分为 8.54),而溃疡性结肠炎患者和克罗恩病患者的平均得分分别为 9.10 和 8.45。我们还发现了一些相关因素,如疾病类型、病程、血便频率和排便频率。

结论

我们的调查显示,炎症性肠病患者在 2019 冠状病毒病大流行期间更关注生活质量的改善和较少的药物治疗。疾病类型、病程、血便频率和排便频率等因素与治疗目标相关。我们的研究结果有助于临床医生了解患者的治疗目标,从而有助于更好地管理炎症性肠病患者。

相似文献

2
The Psychological Effects of COVID-19 Pandemic in Patients with Inflammatory Bowel Disease.
Turk J Gastroenterol. 2022 May;33(5):387-396. doi: 10.5152/tjg.2022.21253.
6
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care.
United European Gastroenterol J. 2020 Dec;8(10):1228-1235. doi: 10.1177/2050640620964132. Epub 2020 Oct 18.
7
Identifying and Predicting the Goals and Concerns Prioritised by Individuals with Inflammatory Bowel Disease.
J Crohns Colitis. 2022 Mar 14;16(3):379-388. doi: 10.1093/ecco-jcc/jjab142.
9
Assessing health-related quality of life in patients with inflammatory bowel disease in Zhejiang, China.
J Clin Nurs. 2010 Jan;19(1-2):79-88. doi: 10.1111/j.1365-2702.2009.03020.x.

本文引用的文献

1
Immunosuppressive Therapy and Risk of COVID-19 Infection in Patients With Inflammatory Bowel Diseases.
Inflamm Bowel Dis. 2021 Jan 19;27(2):155-161. doi: 10.1093/ibd/izaa278.
2
Epidemiology and the Impact of Therapies on the Outcome of COVID-19 in Patients With Inflammatory Bowel Disease.
Am J Gastroenterol. 2020 Oct;115(10):1722-1724. doi: 10.14309/ajg.0000000000000830.
3
The Effect of the COVID-19 Pandemic on the Medical Mode of Patients With Inflammatory Bowel Disease in China.
Inflamm Bowel Dis. 2020 Sep 18;26(10):e116-e117. doi: 10.1093/ibd/izaa197.
4
'Treat to Target' in Mild to Moderate Ulcerative Colitis: Evidence to Support this Strategy.
Curr Drug Targets. 2021;22(1):117-125. doi: 10.2174/1389450121666200727120305.
5
Review of normal gastrointestinal tract, ulcerative colitis, proctitis and rectal medication adherence.
Br J Nurs. 2020 Jul 23;29(14):805-811. doi: 10.12968/bjon.2020.29.14.805.
6
The New Proactive Approach and Precision Medicine in Crohn's Disease.
Biomedicines. 2020 Jul 3;8(7):193. doi: 10.3390/biomedicines8070193.
7
Targeting the gut layers in Crohn's disease: mucosal or transmural healing?
Expert Rev Gastroenterol Hepatol. 2020 Sep;14(9):775-787. doi: 10.1080/17474124.2020.1780914. Epub 2020 Jun 18.
9
Crohn's disease: A retrospective analysis between computed tomography enterography, colonoscopy, and histopathology.
Radiography (Lond). 2019 Nov;25(4):349-358. doi: 10.1016/j.radi.2019.04.007. Epub 2019 May 7.
10
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
Gastroenterology. 2018 Aug;155(2):337-346.e10. doi: 10.1053/j.gastro.2018.04.012. Epub 2018 Apr 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验